Cargando…
Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States
BACKGROUND: Despite its high prevalence and clinical significance, clinical measurement of lipoprotein(a) is rare but has not been systematically quantified. We assessed the prevalence of lipoprotein(a) testing overall, in those with various cardiovascular disease (CVD) conditions and in those under...
Autores principales: | Bhatia, Harpreet S., Hurst, Samantha, Desai, Paresh, Zhu, Wenhong, Yeang, Calvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547299/ https://www.ncbi.nlm.nih.gov/pubmed/37702041 http://dx.doi.org/10.1161/JAHA.123.031255 |
Ejemplares similares
-
Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis
por: Bhatia, Harpreet S., et al.
Publicado: (2022) -
Role of Phospholipid Transfer Protein in High-Density Lipoprotein– Mediated Reverse Cholesterol Transport
por: Yazdanyar, Amirfarbod, et al.
Publicado: (2011) -
Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements
por: Yeang, Calvin, et al.
Publicado: (2021) -
Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020) -
Mycobacterial Testing Trends, United States, 2009–2015
por: Dean, Samantha G., et al.
Publicado: (2020)